Vericel falls as prelim Q4 revenue misses estimates

Vericel

14/01/2025 21:29

** Shares of drugmaker Vericel  VCEL.O  fall 12.7% to $51.25
in extended trading   
    ** VCEL expects prelim Q4 revenue in the range of about
$75.2 million to $75.7 million 
    ** Analysts estimate Q4 revenue of $77.93 mln on average
-data compiled by LSEG 
    ** VCEL expects Q4 gross margin to be ~77% vs estimates of
75.43% 
    ** Co expects 20% to 23% total revenue growth for 2025
    ** As of Dec 31, 2024, co had ~$167 million in cash,
restricted cash and investments, and no debt - VCEL  
    ** Up to last close, stock gained ~53% over the past 12
months 

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))